| Literature DB >> 36120204 |
Pradeep Kumar1, Arun Prasad1, Subhash Kumar2, Ambrin Akhtar1.
Abstract
Neurological manifestations are common in scrub typhus in children. A 12-year-old girl presented with acute onset fever, bilateral lower limb weakness, and urinary retention. On initial investigations, scrub typhus immunoglobulin M (IgM) ELISA (enzyme-linked immunosorbent assay) was reactive. She was given an injection of doxycycline along with other supportive therapies. Her symptoms improved gradually and bilateral lower limb power came back gradually without residual weakness by the 13th day of admission.Entities:
Keywords: afp; doxycycline; ivig; meningoencephalitis; muscle weakness
Year: 2022 PMID: 36120204 PMCID: PMC9467491 DOI: 10.7759/cureus.27909
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Hughes’ grade with subdivision of grades
Reference no. [10]
| Grades | Functions |
| Grade 0 | Normal functional state |
| Grade 1 | Able to run with minor signs and symptoms |
| Grade 2 | Able to walk 5 meters independently |
| Grade 3 | Able to walk 5 meters with aid |
| Grade 4 | Bed or chair bound |
| Grade 5 | With respiratory failure |
| Grade 5 A | With early respiratory failure, no requirement for a ventilator |
| Grade 5 B | Respiratory failure requiring mechanical ventilation |
| Grade 6 | Death |
Medical Research Council (MRC) sum score
Reference no. [11]
| Grade | Degree of Strength |
| 5 | Normal Strength |
| 4 | Ability to resist moderate pressure throughout a range of motion |
| 3 | Ability to move through a full range of motion against gravity. If a subject has a contracture that limits joint movement, the mechanical range will be to the point at which the contracture causes joint restriction |
| 2 | Ability to move through a full range of motion with gravity eliminated |
| 1 | A flicker of motion is seen or felt in the muscle |
| 0 | No movement |
Laboratory investigations
PCV: packed cell volume, MCV: mean corpuscular volume, ESR: erythrocyte sedimentation rate, CPK: creatinine phosphokinase
| Investigation | Normal value | Day 1 | Day 6 | Day 8 |
| Hemoglobin (g/dL) | 11.5–14.5 | 11 | 9.7 | |
| Platelets (per cmm) | 150–450×103 | 150×103 | 179×103 | |
| Leucocyte count (per cmm) | 4,000–11,000 | 11,400 | 8,310 | |
| Differential leucocyte count (%): | ||||
| Neutrophils | 40-80 | 39.9 | 59.1 | |
| Lymphocytes | 20-40 | 57.6 | 35.4 | |
| Monocytes | 2-10 | 1.8 | 2.0 | |
| Eosinophils | 1-6 | 0 | 2.1 | |
| Basophils | 0-1 | 0.7 | 0 | |
| PCV (%) | 35-45 | 83.7 | 87.6 | |
| MCV (fL) | 78-95 | 13.5 | 13.9 | |
| ESR (mm in first hour) | 0-10 | 70 | 43 | |
| Total serum bilirubin (mg/dL) | 0.3–1.2 | 0.83 | 0.59 | |
| Serum direct bilirubin (mg/dL) | <0.2 | 0.26 | 0.25 | |
| Aspartate aminotransferase (IU/L) | <31 | 125.3 | 83.8 | |
| Alanine aminotransferase (IU/L) | 10–28 | 69.5 | 137.1 | |
| Alkaline phosphatase (IU/L) | 100–290 | 103.5 | 112.9 | |
| Total protein | 6.0-8.0 | 6.90 | ||
| Albumin/Globulin (gm/dL) ratio | 0.84 | 0.63 | ||
| Blood urea (mg/dL) | 13–43 | 27.5 | 20.6 | |
| Serum creatinine (mg/dL) | 0.7–1.3 | 0.47 | 0.37 | |
| Serum sodium (mmol/L) | 135–145 | 129.2 | 132.7 | |
| Serum potassium (mmol/L) | 3.5–5 | 4.4 | 4.2 | |
| Serum calcium (mg/dL) | 8.8-10.8 | 8.2 | 8.4 | |
| Serum phosphate (mg/dL) | 3.2-5.8 | 3.5 | 5.2 | |
| C-reactive protein (mg/L) | 0-5 | 29.2 | 12.8 | |
| CPK (IU/L) | 20-180 | 256.78 | 200.32 | |
| Serum ammonia (µmol/L) | 11-32 | 394 |
Serology reports
NS1: non-structural protein 1, IgM: immunoglobulin M, IgG: immunoglobulin G, ELISA: enzyme-linked immune sorbent assay, HIV: human immunodeficiency virus, HBsAg: hepatitis B surface antigen, HCV: hepatitis C virus
| Tests | Reports |
| Malaria card test | Negative |
| Dengue NS1 Antigen, IgM, IgG | All non-reactive |
| Leptospira IgM | Non-reactive |
| Scrub typhus IgM ELISA | Reactive |
| HIV I & II antibody | Non-reactive |
| HBsAg | Negative |
| Anti HCV antibody | Non-reactive |
| Widal test | Negative |
CSF examination reports on different stages of illness
CSF: cerebrospinal fluid, AFB: acid-fast bacilli, CBNAAT: Cartridge based nucleic acid amplification test, ADA: adenosine deaminase, LDH: lactate dehydrogenase
| Parameters | Normal value | Day 1 | Day 9 |
| Volume | 3ml | 3ml | |
| Colour | Colorless | Colorless | Colorless |
| Appearance | Clear | Clear | Clear |
| Cells (mm3) | <5 | 20 | 2 |
| Lymphocytes | ≥75% | 80% | 100% |
| Polymorphs | 0 | 20% | |
| Gram staining | Negative | Negative | Negative |
| AFB staining | Negative | Negative | Negative |
| CBNAAT | Negative | Negative | Negative |
| Culture and sensitivity | No growth | No growth | No growth |
| Protein (mg/dL) | 20-45 | 57.55 | 36.10 |
| Sugar (mg/dL) | >50 (or 75% serum glucose) | 59 | 70.04 |
| ADA (IU/L) | < 10 | 2.76 | < 0.10 |
| LDH (IU/L) | < 40 | 89.85 | 33.95 |
Figure 1MRI brain and spine
MRI (Magnetic Resonance Imaging) brain and spine
A) Axial FLAIR (fluid-attenuated inversion recovery) image of brain showing normal appearance of the brain parenchyma (white arrow)
B) Axial post-contrast T1-FS image of the brain showing the normal appearance, without any abnormal meningeal or parenchymal enhancement (white arrow)
C) Sagittal post-contrast T1-FS image of the whole spine showing the normal appearance, without any abnormal meningeal or spinal cord enhancement (white arrow)
Improvement in neurological parameters
MRC: medical research council, UL: upper limbs, LL: lower limbs
| Neurological parameters | Day1 | Day 4 | Day 9 | Day 13 |
| MRC sum score | 30/60 | 38/60 | 54/60 | 60/60 |
| Hughes’ score | 4 | 4 | 3 | 0 |
| Muscle power UL | 5/5 | 5/5 | 5/5 | 5/5 |
| Muscle power LL | 0/5 | 2/5 | 3/5 | 5/5 |
| Reflexes | Areflexia | Areflexia | Normal | Normal |